| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4050228 | ADME | Drug metabolism in human liver cytosol assessed as AOX-mediated PF-04217903 site 1 oxidative metabolite formation by measuring LC-MS peak area of the metabolite at 10 uM after 30 min in presence of hydralazine by UPLC/Q-TOF MS analysis | Homo sapiens | 1 | ALA4049400 | assay format | Scientific Literature | |
| 2. | ALA4050231 | ADME | Drug metabolism in human liver cytosol assessed as AOX-mediated PF-04217903 site 1 oxidative metabolite formation by measuring LC-MS peak area of the metabolite at 10 uM after 30 min by UPLC/Q-TOF MS analysis | Homo sapiens | 1 | ALA4049400 | assay format | Scientific Literature | |
| 3. | ALA4050236 | ADME | Drug metabolism in human liver cytosol assessed as AOX-mediated PF-04217903 site 1 oxidative metabolite formation by measuring LC-MS peak area of the metabolite at 10 uM after 30 min in presence of menadione by UPLC/Q-TOF MS analysis | Homo sapiens | 1 | ALA4049400 | assay format | Scientific Literature | |
| 4. | ALA4050241 | Unassigned | Retention time of the compound by UPLC/Q-TOF MS analysis | 4 | ALA4049400 | assay format | Scientific Literature | ||
| 5. | ALA4050242 | ADME | Drug level in human liver cytosol treated with PF-04217903 assessed as AOX-mediated metabolite formation at 10 uM after 30 min by UPLC/Q-TOF MS analysis | Homo sapiens | 2 | ALA4049400 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!